NCT06880042

COMPARISON OF EFFICACY AND SAFETY OF NARROWBAND UVB WITH 0.1% TACROLIMUS VS NARROWBAND UVB WITH 0.005% CALCIPOTRIOL IN TREATMENT OF VITILIGO

• Status: Enrolling By Invitation
• Phase: EARLY_Phase 1
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Dr ayesha wahid · Other Government
• Sex: All
• Age: 15 Years – 70 Years
• Healthy volunteers: Accepted

Summary

Patient of stable and limited vitiligo less than 20% BSA will be recruited And evaluation of efficacy and safety of narrowband UVB with topical tacrolimus vs narrowband UVB and calcipotriol will be assessed

Detailed description

Evaulation of efficacy and safety of narrowband uvb and tacrolimus and NBUVB and calcipotriol in patient if stable vitiligo with body surface area less than 20% It will be assessed by VASI score and VIisual analogie scale

Conditions

• Vitiligo - Macular Depigmentation
• Tacrolimus

Interventions

Type	Name	Description
DRUG	Tacrolimus	Tacrolimus is calcineurin inhibitor that will act as immunomodulator
DRUG	Calcipotriol	Calcipotriol is a vitamin D analogue that will act as immunomodulator

Timeline

• Start date: 2025-05-01
• Primary completion: 2025-06-30
• Completion: 2025-08-30
• First posted: 2025-03-17
• Last updated: 2025-06-24

Locations

1 site across 1 country: Pakistan